XML 22 R10.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENTS
6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
SEGMENTS

4. SEGMENTS

 

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision-maker is the CEO. The Company operates in and reports four business segments: real estate, digital transformation technology, biohealth, and other business activities. The Company’s reportable segments are determined based on the services they perform and the products they sell, not on the geographic area in which they operate. The Company’s chief operating decision maker evaluates segment performance based on segment revenue. Costs excluded from segment income (loss) before taxes and reported as “Other” consist of corporate general and administrative activities which are not allocable to the four reportable segments.

 

 

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the six months ended June 30, 2024 and 2023:

 

   Real Estate   Digital Transformation Technology   Biohealth Business   Other   Total 
                     
Six Months Ended on June 30, 2024                         
Revenue  $6,458,005   $-   $-   $755,248   $7,213,253 
Cost of Sales   (5,181,322)   -    (3,387)   (303,616)   (5,488,325)
Gross Profit (Loss)   1,276,683    -    (3,387)   451,632    1,724,928 
Operating Expenses   (939,866)   (290,635)   (1,115,063)   (4,455,348)   (6,800,912)
Operating Income (Loss)   336,817    (290,635)   (1,118,450)   (4,003,716)   (5,075,984)
Other Income (Expense)   422,319    (1,850,609)   (99,845)   (1,859,637)   (3,387,772)
Net Income (Loss) Before Income Tax   759,136    (2,141,244)   (1,218,295)   (5,863,353)   (8,463,756)

 

   Real Estate   Digital Transformation Technology   Biohealth Business   Other   Total 
                     
Six Months Ended on June 30, 2023                         
Revenue  $19,515,728   $28,074   $12,786   $524,196   $20,080,784 
Cost of Sales   (12,168,470)   (9,139)   (109,657)   (140,508)   (12,427,774)
Gross Profit (Loss)   7,347,258    18,935    (96,871)   383,688    7,653,010 
Operating Expenses   (992,201)   (202,430)   (477,917)   (2,960,696)  $(4,633,244)
Operating Income (Loss)   6,355,057    (183,495)   (574,788)   (2,577,008)   3,019,766 
Other Income (Expense)   215,306    (1,091,514)   835,888    (13,116,034)  $(13,156,354)
Net Income (Loss) Before Income Tax   6,570,363    (1,275,009)   261,100    (15,693,042)   (10,136,588)
                          
June 30, 2024                         
Cash and Restricted Cash  $4,024,232   $198,995   $450,636   $15,089,517   $19,763,380 
Total Assets   52,381,204    3,690,191    2,839,056    34,550,370    93,460,821 
                          
December 31, 2023                         
Cash and Restricted Cash  $3,323,210   $430,807   $568,702   $23,566,574   $27,889,293 
Total Assets   62,989,233    5,845,269    2,450,876    55,028,650   $126,314,028